牛 娜, 林岩松. Application and research progress of selective internal radiation therapy with90Y microspheres in hepatocellular carcinoma[J]. China Oncology, 2021, 31(5): 428-434.
牛 娜, 林岩松. Application and research progress of selective internal radiation therapy with90Y microspheres in hepatocellular carcinoma[J]. China Oncology, 2021, 31(5): 428-434. DOI: 10.19401/j.cnki.1007-3639.2021.05.009.
Application and research progress of selective internal radiation therapy with90Y microspheres in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related deaths in China. About 85% of HCC patients are at intermediate or advanced stage upon diagnosis
of which the common treatment strategy is the combination of systemic therapy (including chemotherapy
targeted therapy and immunotherapy) and local minimally invasive therapy (such as interventional therapy and radiotherapy). As one of the local minimally invasive treatment modalities
selective internal radiation thera
py (SIRT) with yttrium-90 (
90
Y) microspheres has been used for nearly 20 years abroad with confirmed efficacy and safety. Benefit in local control of HCC by using SIRT with
90
Y microspheres alone or being combined with surgery
immunotherapy and targeted drugs has been demonstrated. Meanwhile
the “radiation resection” effect of SIRT with
90
Y microsphere on liver segments sheds light on its promising clinical use as radical treatment for HCC. Herein
the application and recent progress of SIRT with
90
Y microspheres in HCC were reviewed in terms of its therapeutic purpose as palliative